Display options
Share it on

J Gerontol A Biol Sci Med Sci. 2016 Nov;71(11):1472-1475. doi: 10.1093/gerona/glw037. Epub 2016 Mar 09.

Cystatin C and Objectively Measured Mobility 10 Years Later in Older Women.

The journals of gerontology. Series A, Biological sciences and medical sciences

Kristine E Ensrud, Li-Yung Lui, Peggy Cawthon, Lisa Fredman, Yelena Slinin, Teresa Hillier, Jane Cauley, Muna Canales,

Affiliations

  1. Department of Medicine and Division of Epidemiology & Community Health, University of Minnesota, Minneapolis. Department of Medicine, VA Health Care System, Minneapolis, Minnesota. [email protected].
  2. California Pacific Medical Center Research Institute, San Francisco.
  3. Department of Epidemiology, Boston University, Massachusetts.
  4. Department of Medicine and Department of Medicine, VA Health Care System, Minneapolis, Minnesota.
  5. Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon.
  6. Department of Epidemiology, University of Pittsburgh, Pennsylvania.
  7. Department of Medicine, Malcom-Randall VA Medical Center, Gainesville, Florida. Department of Medicine, University of Florida, Gainesville.

PMID: 26961582 PMCID: PMC5055645 DOI: 10.1093/gerona/glw037

Abstract

BACKGROUND: Serum biomarkers predicting physical performance in late life are uncertain. We tested the hypotheses that lower serum cystatin C (cysC) in older women is associated with good mobility 10 years later.

METHODS: We conducted a longitudinal analysis of a prospective cohort of 1,384 women attending Year 10 and Year 20 examinations of the Study of Osteoporotic Fractures. Serum cysC was measured using Year 10 frozen serum specimens. Year 20 mobility was ascertained by the Short Physical Performance Battery; scores of 10-12 indicated good mobility.

RESULTS: At Year 20, mean age was 87.5 years and 364 women (26.3%) had good mobility. After adjustment for age, race, education, health status, diabetes, cardiovascular disease, and body mass index, lower cysC at Year 10 was associated with a higher likelihood of good mobility at Year 20. Compared with quartile (Q) 4 of cysC (referent group), odds ratios (95% confidence interval) were 1.52 (1.02-2.25) for Q3, 1.93 (1.32-2.84) for Q2 and 1.80 (1.21-2.67) for Q1 (p trend across Qs .003). The association was only modestly attenuated after further adjustment for mobility as assessed by a modified Short Physical Performance Battery at Year 10 (p trend .02) or consideration of potential biologic mediators including Year 10 levels of serum 25-hydroxyvitamin D, interleukin 6, and cytokine soluble receptors (p trend .04).

CONCLUSIONS: Lower cysC in older women is independently associated with good mobility 10 years later and may be a biomarker for successful aging as manifested by preservation of lower extremity performance in late life.

Published by Oxford University Press on behalf of the Gerontological Society of America 2016.

Keywords: Aging; Cystatin C; Physical performance

References

  1. J Gerontol A Biol Sci Med Sci. 2014 Mar;69(3):301-7 - PubMed
  2. N Engl J Med. 2013 Sep 5;369(10):932-43 - PubMed
  3. N Engl J Med. 2012 Jul 5;367(1):20-9 - PubMed
  4. Scand J Clin Lab Invest. 1999 Feb;59(1):1-8 - PubMed
  5. Arch Intern Med. 2008 Jan 28;168(2):147-53 - PubMed
  6. JAMA. 1990 Feb 2;263(5):665-8 - PubMed
  7. J Am Geriatr Soc. 2006 May;54(5):750-6 - PubMed
  8. J Gerontol A Biol Sci Med Sci. 2000 Dec;55(12):M709-15 - PubMed
  9. J Gerontol. 1994 Mar;49(2):M85-94 - PubMed
  10. Kidney Int. 2009 Mar;75(6):652-60 - PubMed
  11. Kidney Int. 2004 Apr;65(4):1416-21 - PubMed
  12. Am J Epidemiol. 2006 Dec 15;164(12):1180-9 - PubMed
  13. J Gerontol A Biol Sci Med Sci. 2011 Oct;66(10):1083-9 - PubMed
  14. Circulation. 2003 Jan 7;107(1):87-92 - PubMed
  15. J Clin Endocrinol Metab. 2007 Jun;92(6):2058-65 - PubMed
  16. Ann Clin Biochem. 2002 Mar;39(Pt 2):89-104 - PubMed

Publication Types

Grant support